Owens & Minor, Inc. (NYSE: OMI) announced on December 18, 2025 that it will change its corporate name to Accendra Health, Inc. and will trade under the new ticker symbol “ACH” beginning on January 2, 2026. The name change takes effect on December 31, 2025, and the new website www.accendrahealth.com will launch on the same day, aligning the company’s digital presence with its new identity.
The rebranding follows the sale of the company’s Products & Healthcare Services (P&HS) segment to Platinum Equity for $375 million in cash. The divestiture removed a lower‑margin, lower‑growth business that had accounted for roughly 20 % of total revenue in 2024, allowing Accendra Health to focus exclusively on its Patient Direct segment, which includes the Apria and Byram Healthcare brands. Management believes the streamlined structure will improve operational leverage and unlock a higher valuation for a pure‑play home‑based care provider.
Financially, Owens & Minor reported a debt balance of $2.24 billion as of late 2025. The proceeds from the P&HS sale are expected to reduce leverage over the next few years, supporting a return to profitability. Analysts project earnings per share of $1.05 for the current year, reflecting the company’s confidence in cost discipline and the growth potential of the home‑care market. The company’s focus on patient‑direct services is positioned to benefit from demographic trends that favor in‑home care and from technological advances that lower service delivery costs.
CEO Edward A. Pesicka said the rebranding marks “another milestone in the strategic transformation of our company as a leading, pure‑play home‑based care business that puts the patient first while consistently delivering long‑term profitable growth.” He emphasized that the company’s commitment to quality patient care remains unchanged and that the new name signals an “exciting next chapter” for the organization.
The transition to Accendra Health is expected to clarify the company’s market positioning, improve investor understanding of its growth prospects, and support a more focused capital allocation strategy. By shedding the legacy P&HS segment, the company can concentrate resources on expanding its home‑care portfolio, which is projected to grow faster than the broader healthcare services industry. The rebranding also aligns Accendra Health with industry trends toward decentralized care, potentially enhancing its competitive advantage in a rapidly evolving market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.